Down-regulation of lipoxin A4 receptor by thromboxane A 2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo

Biomedicine and Pharmacotherapy

Volumn 58, Issue 6-7, 2004, Pages 381-387

  Sato, Yoshinori ^a   Kitasato, Hidero ^a   Murakami, Yousuke ^a   Hashimoto, Atsushi ^a   Endo, Hirahito ^a   Kondo, Hirobumi ^a   Inoue, Matsuhisa ^a   Hayashi, Izumi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

IL; Interleukin; lipoxin; Lipoxin A4 receptor; Lung fibrosis; LX; PG; prostaglandin; reverse transcription polymerase chain reaction; RT PCR; TGF; Thromboxane; Thromboxane A2; transforming growth factor; TX

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANTIINFLAMMATORY AGENT; BLEOMYCIN; COLLAGEN TYPE 1; FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 1BETA; LIPOXIN A; LIPOXIN A2; MESSENGER RNA; NAFAGREL; RECEPTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; THROMBOXANE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BLEOMYCIN; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IMIDAZOLES; INTERLEUKIN-1; LIPOXINS; LUNG; MICE; NIH 3T3 CELLS; PULMONARY FIBROSIS; RECEPTORS, LIPOXIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRANSFORMING GROWTH FACTOR BETA; VASOCONSTRICTOR AGENTS;

EID: 3242729490     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.05.006     Document Type: Article

References (48)

1. Romano M., Serhan C.N. Lipoxin generation by permeabilized human platelets. Biochemistry. 31:1992;8269-8277
2. Serhan C.N. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins. 53:1997;107-137
3. Levy B.D., Romano M., Chapman H.A., Reily J.J., Drazen J., Serhan C.N. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 92:1993;1572-1579
4. Clària J., Lee M.H., Serhan C.N. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med. 2:1996;583-596
5. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med. 185:1997;1693-1704
6. 4. Nat Med. 8:2002;1018-1023
7. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 68-69:2002;433-455
8. Kieran N.E., Doran P.P., Connolly S.B., Greenan M.C., Higgins D.F., Leonard M., et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64:2003;480-492
9. Goh J., Godson C., Brady H.R., Macmathuna P. Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology. 124:2003;1043-1054
10. 4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med. 196:2002;1253-1262
11. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., Sjer A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol. 3:2002;76-82
12. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol. 168:2002;5260-5267
13. Nassar G.M., Badr K.F. Novel approaches to treatment of glomerulonephritis. J Nephrol. 11:1998;177-184
14. Serhan C.N., Takano T., Gronert K., Chiang N., Clish C.B. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. Clin Chem Lab Med. 37:1999;299-309
15. Clarkson M.R., McGinty A., Godson C., Brady H.R. Leukotrienes and lipoxins: lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis. Nephrol Dial Transplant. 13:1998;3043-3051
16. Ye R.D., Cavanagh S.L., Quehenberger O., Prossnitz E.R., Cochrane C.G. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun. 184:1992;582-589
17. Murphy P.M., Ozcelik T., Kenney R.T., Tiffany H.L., McDermott D., Francke U. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem. 267:1992;7637-7643
18. Bao L., Gerard N.P., Eddy R.L., Shows T.B., Gerard C. Mapping genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics. 13:1992;437-440
19. Perez H.D., Holmes R., Kelly E., McClary J., Andrews W.H. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene. 118:1992;303-304
20. 4 receptor. J Exp Med. 180:1994;253-260
21. Devchand P.R., Arita M., Hong S., Bannenberg G., Moussignac R.L., Gronert K., et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17:2003;652-659
22. 4. Scand J Immunol. 56:2002;470-476
23. 2+ increase in human bronchial epithelium. J Biol Chem. 278:2003;10879-10884
24. 4's anti-inflammatory actions on intestinal epithelium. Am J Physiol Cell Physiol. 284:2003;C888-C896
25. 4R. Blood. 101:2003;1572-1581
26. 4 inhibits IL-1β-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol. 164:2000;2660-2666
27. Samuelsson B., Goldyne M., Granstrom E., Hamberg M., Hammarstrom S., Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 47:1978;997-1029
28. di Minno G., Bertele V., Bianchi L., Barbieri B., Celetti C., Dejana E., et al. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. Thromb Haemost. 45:1981;103-106
29. 2 synthase suppresses lung injury induced by bleomycin. Am J Respir Cell Mol Biol. 28:2003;582-591
30. Takami M., Tsukada W. Effects of DP-1904, a thromboxane synthetase inhibitor, on the antigen-induced airway hyperresponsiveness and infiltration of inflammatory cells in guinea-pigs. Prostaglandins Leukot Essent Fatty Acids. 59:1998;407-414
31. Packham M.A. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 72:1994;278-284
32. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA. 71:1974;345-349
33. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA. 72:1975;2994-2998
34. Diczfalusy U., Hammarstrom S. A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes. FEBS Lett. 105:1979;291-295
35. Hammarstrom S., Diczfalusy U. Biosynthesis of thromboxanes. Adv Prostaglandin Thromboxane Res. 6:1980;267-274
36. 2 receptor: cDNA cloning, expression and northern blot analysis. Biochem Biophys Res Commun. 184:1992;1197-1203
37. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 331:1994;1286-1292
38. Zhang K., Phan S.H. Cytokines and pulmonary fibrosis. Biol Signals. 5:1996;232-239
39. Bonnew J.C., Rice A.B., Ingram J.L., Moomaw C.R., Nyska A., Bradbury A., et al. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol. 16:2002;459-470
40. Chandler D.B., Giri S.N., Chen Z., Hyde D.M. The in vitro synthesis and degradation of prostaglandins during the development of bleomycin-induced pulmonary fibrosis in hamsters. Prostaglandins Leukotrienes Med. 11:1983;11-31
41. Moore B.B., Coffey M.J., Christensen P., Sitterding S., Ngan R., Wilke C.A., et al. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Imunol. 165:2000;4032-4039
42. 2 in the lung. Chest. 121:2002;102S-104S
43. McAnulty R.J., Chambers R.C., Laurent G.J. Regulation of fibroblast procollagen production. Biochem J. 307:1995;63-68
44. 2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis. Int J Exp. Path. 80:1999;41-49
45. Keerthisingam C.B., Jenkins R.G., Harrison N.K., Hernandez-Rodriguez N.A., Booth H., Laurent G.J., et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibritic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 158:2001;1411-1422
46. Risk C., Rie M., Peterson M., Kong D., Woods B., Watkins W.D. Thromboxane and prostacyclin (epoprostenol) during exercise in diffuse pulmonary fibrosis. Lancet. 2:1982;1183-1185
47. Chandler D.B., Giri S.N., Chen Z., Hyde D.M. The in vitro synthesis and degradation of prostaglandins during the development of bleomycin-induced pulmonary fibrosis in hamsters. Prostaglandins Leukot Med. 11:1983;11-31
48. 2 and collagen levels of the lung in hamsters. Exp Lung Res. 9:1985;119-133